Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Alperi

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Rheumatology|January 24, 2020
Disease Activity in Psoriatic Arthritis Index and Psoriatic Arthritis Impact of Disease Questionnaire: correlation and sensitivity to change in a real clinical settingEstefanía Pardo, Lilyan Charca, Sara Alonso, et al.
Joint Bone Spine|May 6, 2008
Clinical expression, but not disease outcome, may vary according to age at disease onset in psoriatic spondylitisRuben Queiro, Mercedes Alperi, Alejandra Lopez, et al.
Frontiers in Immunology|February 2, 2018
Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical BiomarkerJavier Rodríguez-Carrio, Mercedes Alperi-López, Patricia López, et al.
Plos One|August 4, 2016
Non-Esterified Fatty Acids Profiling in Rheumatoid Arthritis: Associations with Clinical Features and Th1 ResponseJavier Rodríguez-Carrio, Mercedes Alperi-López, Patricia López, et al.
Journal of Personalized Medicine|August 27, 2025
Tailoring Inflammatory Biomarker Assessment in Axial Spondyloarthritis: A Comparative Study of Erythrocyte Sedimentation Rate and C-Reactive Protein Across Disease ProfilesRubén Queiro, Sara Alonso, Stefanie Burger, et al.
Frontiers in Immunology|October 30, 2018
Profiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment OutcomesJavier Rodríguez-Carrio, Mercedes Alperi-López, Patricia López, et al.
Journal of Clinical Medicine|January 21, 2023
Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center ExperienceIgnacio Braña, Estefanía Pardo, Stefanie Burger, et al.
Rheumatology International|December 22, 2011
Psoriasis and psoriasiform lesions induced by TNFα antagonists: the experience of a tertiary care hospital from northern SpainAlejandra López-Robles, Rubén Queiro, Mercedes Alperi, et al.
Expert Review of Clinical Pharmacology|May 17, 2025
Golimumab retention in patients with psoriatic arthritis and axial spondyloarthritis: evidence from up to a decade of follow-upPaula Alvarez, Arancha Gómez-Cosme, Pablo González Del Pozo, et al.
Journal of Clinical Medicine|March 11, 2023
Are Patients with Axial Spondyloarthritis Who Were Breastfed Protected against the Development of Severe Disease?Sara Alonso, Ignacio Braña, Estefanía Pardo, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Rheumatology|January 24, 2020
Disease Activity in Psoriatic Arthritis Index and Psoriatic Arthritis Impact of Disease Questionnaire: correlation and sensitivity to change in a real clinical settingEstefanía Pardo, Lilyan Charca, Sara Alonso, et al.
Joint Bone Spine|May 6, 2008
Clinical expression, but not disease outcome, may vary according to age at disease onset in psoriatic spondylitisRuben Queiro, Mercedes Alperi, Alejandra Lopez, et al.
Frontiers in Immunology|February 2, 2018
Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical BiomarkerJavier Rodríguez-Carrio, Mercedes Alperi-López, Patricia López, et al.
Plos One|August 4, 2016
Non-Esterified Fatty Acids Profiling in Rheumatoid Arthritis: Associations with Clinical Features and Th1 ResponseJavier Rodríguez-Carrio, Mercedes Alperi-López, Patricia López, et al.
Journal of Personalized Medicine|August 27, 2025
Tailoring Inflammatory Biomarker Assessment in Axial Spondyloarthritis: A Comparative Study of Erythrocyte Sedimentation Rate and C-Reactive Protein Across Disease ProfilesRubén Queiro, Sara Alonso, Stefanie Burger, et al.
Frontiers in Immunology|October 30, 2018
Profiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment OutcomesJavier Rodríguez-Carrio, Mercedes Alperi-López, Patricia López, et al.
Journal of Clinical Medicine|January 21, 2023
Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center ExperienceIgnacio Braña, Estefanía Pardo, Stefanie Burger, et al.
Rheumatology International|December 22, 2011
Psoriasis and psoriasiform lesions induced by TNFα antagonists: the experience of a tertiary care hospital from northern SpainAlejandra López-Robles, Rubén Queiro, Mercedes Alperi, et al.
Expert Review of Clinical Pharmacology|May 17, 2025
Golimumab retention in patients with psoriatic arthritis and axial spondyloarthritis: evidence from up to a decade of follow-upPaula Alvarez, Arancha Gómez-Cosme, Pablo González Del Pozo, et al.
Journal of Clinical Medicine|March 11, 2023
Are Patients with Axial Spondyloarthritis Who Were Breastfed Protected against the Development of Severe Disease?Sara Alonso, Ignacio Braña, Estefanía Pardo, et al.
Pageof 8